Diagnoptics News

What's new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

DiagnOptics receives ISO 13485 certification.

DiagnOptics has received ISO 13485 certification for the design, development, manufacture, sales and support of the AGE Reader.

The Dutch Groningen based medical technology company DiagnOptics announces that it has received the ISO 13485 certificate. ISO 13485 is the equivalent of ISO 9001 for manufacturers of medical devices. ISO 13485 verifies that a medical device manufacturer complies with the appropriate regulatory quality system requirements and it assumes that the manufacturer has the appropriate controls in place to ensure that the device developed and manufactured can be considered safe and effective.

Together with the CE certification, this certification enables DiagnOptics to achieve regulatory approval of the AGE Reader in countries outside the European Union. DiagnOptics’ managing director Bart van den Berg: ‘We are very pleased with obtaining the ISO 13485 certification. This certification gives us to opportunity to expand the marketing of the AGE Reader to important markets like the USA, China, Canada and Russia.’

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.